{
    "code": "02020509",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02020509",
    "time": "2022-12-30 03:39:51",
    "許可證字號": "衛署藥輸字第020509號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/06\/27",
    "發證日期": "108\/01\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202050904",
    "中文品名": "樂命達錠50毫克",
    "英文品名": "LAMICTAL TABLETS 50MG",
    "適應症": "1. 癲癇(泛發性強直陣攣性發作及簡單性或複雜性局部發作)成人與12歲以上兒童之單獨用藥治療；成人與2歲以上兒童之輔助性治療。\r\n2. 成人與2歲以上兒童Lennox-Gastaut Syndrome徵候群癲癇發作之輔助治療。\r\n3. 處於明顯鬱期之雙極性疾患情感症狀之治療，有明顯鬱期或鬱-躁期循環之雙極性疾患之情感症狀之預防。",
    "劑型": "110錠劑",
    "包裝": "8-1000錠盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "90\/06\/27",
    "主成分略述": "LAMOTRIGINE",
    "限制項目": "02輸　入",
    "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FPL0007000  Delpharm Poznan Spolka Akcyjna",
            "製造廠廠址": "UL. GRUNWALDZKA 189, 60-322 POZNAN, POLAND",
            "製造廠公司地址": "",
            "製造廠國別": "POLAND",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812001600",
            "成分名稱": "LAMOTRIGINE",
            "含量描述": "50",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "1cm*1cm 錠劑",
        "特殊劑型": "",
        "顏色": "淡黃色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "四方形",
        "標記一": "GSEE1",
        "標記二": "50"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020205090005-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=005&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Lamictal tablets 50mg and 100mg PI_20221114-111-11-17(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=052&Type=9"
        },
        {
            "title": "2021-04-13-tw-pi-Lamictal 50mg and 100mg-IPI27-working copy-ch_clean v3 (002)-111-01-07.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=050&Type=9"
        },
        {
            "title": "自行變更Lamictal 50mg CR blister 62000000067975 2x15 tablets-111-04-22(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=013&Type=8"
        },
        {
            "title": "Lamictal tab 50mg外盒-110-06-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=012&Type=8"
        },
        {
            "title": "附件3. Lamictal tab 50mg CR pack-109-12-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=011&Type=8"
        },
        {
            "title": "Lamictal DC 50mg Tablets_-109-12-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02020509&Seq=010&Type=8"
        }
    ]
}